课题基金 / 基金详情

GATA3 in T cell maturation/T helper cell differentiation

GATA3 in T cell maturation/T helper cell differentiation
GATA3 在 T 细胞成熟/T 辅助细胞分化中的作用
批准号:
6725301
负责人:
SUNG-YUN PAI
金额:
$12.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2006-03-31

项目摘要

项目成果

SUNG-YUN PAI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): GATA3, a T cell-specific transcription factor, plays two central roles in immune development. First, it is necessary for the T lymphoid lineage development. Second, it directs the differentiation of T helper type 2 lymphocytes (Th2 cells) and induces the production of Th2 cytokines, such as IL-4, IL-5 and IL-13. Th2 cells mediate the immune response in allergy, asthma, and parasitic infection. Because RAG-chimeric GATA3- deficient mice have an extremely early block in T cell development, little is known about GATA3 function in vivo. Likewise, the mechanism by which GATA3 induces Th2 cytokine production remains unclear. We hypothesize that 1) GATA3 has essential functions in thymocyte development, mature T cell migration, and maintenance of the Th2 phenotype; and 2) GATA3 has distinct structural components that are required for the production of specific cytokines. We propose in Aim 1 to generate a mouse conditionally deficient in GATA3, such that only T cells at the double positive thymocyte stage and beyond lack GATA3, and a tetracycline-responsive GATA3-expressing transgenic mouse. Using the conditional knockout and transgenic models we will study the role of GATA3 in thymocyte development, mature T cell migration and maintenance of the Th2 phenotype. Substitution with other GATA factors can give us insight into the unique and shared domains that define GATA3 function. We have preliminary data, using substitution experiments in vitro and in vivo, that distinct structural domains of GATA3 are necessary for the production of IL-4, IL-5 and IL-13. In Aim 2, we describe how these data will guide our investigation of the role of DNA binding, protein expression level, acetylation of GATA3, induction of other Th2 transcription factors, and as yet undiscovered partners of GATA3 in the mechanism of Th2 cytokine production. The study of GATA3 in vivo and in vitro has important implications for the therapy of Th2-mediated disease such as allergy, asthma, and the response to parasitic infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
  • 批准号:
    9312746
  • 项目类别:
  • 资助金额:
    $59.84万
  • 财政年份:
    2016
  • 负责人:
    SUNG-YUN PAI
  • 依托单位:
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
  • 批准号:
    9143841
  • 项目类别:
  • 资助金额:
    $113.23万
  • 财政年份:
    2016
  • 负责人:
    SUNG-YUN PAI
  • 依托单位:
国内基金
海外基金
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
  • 批准号:
    82371192
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    田婕
  • 依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
  • 批准号:
    82372160
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈峰
  • 依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
  • 批准号:
    82370988
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    经典
  • 依托单位: